Group 1 - The core viewpoint of the news is that Aomei Medical (002950) is experiencing a significant decline in expected profits for 2025, primarily due to asset impairment and credit provisions [1][2][3] Group 2 - As of January 30, 2026, Aomei Medical's stock closed at 11.56 yuan, down 1.87%, with a turnover rate of 2.6% and a trading volume of 117,600 shares, amounting to a transaction value of 136 million yuan [1] - The company anticipates a net profit attributable to shareholders for 2025 between 215.50 million yuan and 257.50 million yuan, representing a year-on-year decline of 30.16% to 41.55% [1][3] - Aomei Medical plans to recognize a total asset impairment provision of approximately 271 million yuan, which will reduce the total profit for 2025 by 208.63 million yuan [2][3] - The company expects its earnings per share for 2025 to be between 0.35 yuan and 0.41 yuan, with a net profit after deducting non-recurring gains and losses projected between 18 million yuan and 22.15 million yuan [1]
股市必读:奥美医疗(002950)预计2025年全年每股收益盈利:0.35元至0.41元